Whilst the MHRA-approved product information does not list heavy menstrual bleeding as a recognised adverse effect, some women report changes in menstrual patterns during treatment
Front Plant Sci 13:1038598 Yang Y, Saand MA, Huang L, Abdelaal WB, Zhang J, Wu Y, Li J, Sirohi MH, Wang F (2021) Applications of multi-omics technologies for crop improvement
35, n o 4, 531544 (ISSN 0741-238X et 1865-8652, PMID 29536338, PMCID 5910468, DOI 10.1007/s12325-018-0677-1, lire en ligne, consult le (en) Charlotte Granhall, Morten Donsmark, Thalia M
In more recent times, lorcaserin (Belviq) was also withdrawn, due to an increased risk (albeit only 9%) of cancer [49] , which the FDA deemed as not being outweighed by the benefits of lorcaserin for any identifiable patient population
You can book one-on-one coaching sessions, choose your preferred format (email, webinar, or live), and set personal goals